Medical and Healthcare Products Import Export Tender and Transport Offers

Paxzen Tablet is intended to treat mild-to-moderate coronavirus disease(COVID-19) in adults and children aged 12 years and older weighing at least 40 kg with a positive COVID-19 test and at risk of progression to severe disease. It reduces the ability of the coronavirus to multiply in the body

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of a nirmatrelvir/ritonavir combination used to treat COVID-19 and sold under the brand name Paxlovid